Blog - Page 2 of 5709 - QualityStocks

TuesdayAug 11, 2026 9:00 am

Earth Science Tech Inc. (ETST) Q1 2027 Financial and Operational Results Reflect Compounding Progress of Expansion Strategy

Earth Science Tech, a growing healthcare holding company, recently reported its Q1 2027 financial results, with key highlights including $9.0 million in revenue, $6.3 million in gross profit, $715,697 in net income, $707,131 in net cash, and $10.4 million in total assets. According to the CEO, the Q1 2027 figures reflect steady, compounding progress and are the result of a foundation built in the 2026 financial year. The company’s strategy of carefully acquiring and scaling cash-flowing assets across healthcare, pharmaceutical, and telemedicine sectors, is driving growth to support uplisting and attract institutional capital. Earth Science Tech (OTC: ETST), a diversified…

MondayAug 10, 2026 3:30 pm

QualityStocksNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Pursues Strategic Growth in Emerging Critical Minerals Region

Greenland Mines (NASDAQ: GRML) is pursuing a diversified critical minerals strategy focused on Greenland as demand for resources essential to electric vehicles, renewable energy, semiconductors, advanced computing and defense technologies continues to grow. The company aims to build a portfolio of projects spanning multiple strategically important commodities rather than relying on a single mineral, while also pursuing acquisitions and partnerships to expand its position. A recent article highlights Greenland’s substantial geological potential and growing international attention as governments seek more secure and diversified mineral supply chains. Greenland Mines plans to advance prospective assets through exploration and geological evaluation while emphasizing responsible…

MondayAug 10, 2026 2:43 pm

QualityStocksNewsBreaks – Forward Industries Inc. (NASDAQ: FWDI) Expands Solana Holdings and Institutional Capital Access

Forward Industries (NASDAQ: FWDI) expanded its Solana treasury by more than 500,000 SOL during fiscal Q3 2026 at an average purchase price of approximately $79 per SOL, bringing its holdings to 7.55 million SOL as of June 30. The company also sold 93,642 shares through its at-the-market offering while reporting 36% annualized SOL-per-share growth, which it says demonstrates its ability to raise capital in an accretive manner. Following inclusion in the Russell 2000 and Russell 3000 indexes, Forward says it has additional access to institutional capital, while its proprietary fwdSOL staking token provides another source of liquidity. To view the full…

MondayAug 10, 2026 10:50 am

QualityStocksNewsBreaks – AZIO AI Holdings, Inc. (NASDAQ: AZIO) Featured in AINewsWire Editorial on AI Power, Infrastructure Demand

AZIO AI Holdings (NASDAQ: AZIO) is featured in an AINewsWire editorial titled “As AI Races Ahead, the Real Battle Is Over Power and Infrastructure,” examining how accelerating artificial intelligence adoption is driving demand for the physical infrastructure required to support AI computing. The editorial highlights AZIO AI integrated infrastructure strategy, including its planned 500-megawatt Texas AI data-center campus, Master Services Agreement with AT&T for enterprise fiber connectivity and power purchase and AI infrastructure hosting agreement with Power Champion Investment Limited. The editorial also highlights AZIO AI recently announced letter of intent with Power Champion for the proposed acquisition of 128…

MondayAug 10, 2026 9:45 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) is Advancing Gold and Silver Assets in One of the World’s Most Productive Mining Jurisdictions

Disseminated on behalf of Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) and may include paid advertising. Lahontan Gold Corp. is a dual-listed Canadian/U.S. mine development and exploration company advancing a portfolio of gold and silver assets across Nevada's Walker Lane, one of the world's premier mining jurisdictions. The company’s flagship Santa Fe Mine historically produced more than 359,000 ounces of gold and 702,000 ounces of silver and is being advanced toward a potential restart, supported by an expanding resource base and existing infrastructure. Led by Founder, CEO and President Kimberly Ann, Lahontan combines experienced leadership with a disciplined development strategy…

MondayAug 10, 2026 9:30 am

QualityStocksNewsBreaks – MAX Power Mining Corp. (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) Secures $10 Million Strategic Private Placement With Eric Sprott

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) announced a strategic non-brokered private placement with Eric Sprott for gross proceeds of $10 million. The financing consists of 4 million units priced at $2.50 each, to be subscribed for by 2176423 Ontario Ltd., a corporation beneficially owned by Sprott. Each unit includes one common share and one warrant exercisable at $3.25 for 24 months. Closing is anticipated on or about Aug. 17, 2026, subject to customary conditions, including Canadian Securities Exchange approval. MAX Power…

MondayAug 10, 2026 9:10 am

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS into Phase 2

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM) announced that the U.S. Food and Drug Administration has approved its Investigational New Drug (“IND”) application for Lucid-MS (Lucid-21-302), clearing the company to advance the patented, first-in-class multiple sclerosis candidate into Phase 2 clinical development. The planned randomized, double-blind, placebo-controlled study will evaluate efficacy, safety and tolerability in people with MS using clinical and radiological measures. Trial start-up activities, including site selection, are underway, with patient enrollment and drug administration expected to begin as quickly as possible. Lucid-MS…

MondayAug 10, 2026 9:00 am

Nightfood Holdings Inc. (NGTF) Positions TechForce Robotics as the Intelligence Layer Behind Autonomous Enterprise Workforces

TechForce Robotics recently launched its proprietary Robotic Connective Network to enable autonomous robots and AI systems to coordinate enterprise workflows. The company's Robotics as a Service platform combines intelligent software, autonomous robotics, and recurring revenue opportunities across multiple industries. These developments reinforce TechForce's broader vision of creating connected robotic ecosystems that operate as coordinated autonomous workforces. Nightfood Holdings (OTCQB: NGTF), doing business as TechForce Robotics, is advancing enterprise automation beyond standalone robots with the launch of its proprietary Robotic Connective Network, a technology framework designed to allow autonomous robots, AI systems, sensors and enterprise software to communicate, coordinate and execute…

FridayAug 07, 2026 2:55 pm

QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Closer to Regulatory and Commercial Milestones

Regentis Biomaterials (NYSE American: RGNT) is advancing its GelrinC hydrogel-based cartilage regeneration technology toward key clinical, regulatory and commercial milestones amid growing interest in regenerative orthopedic solutions. GelrinC is an off-the-shelf, cell-free implant designed for a streamlined, single-step procedure that supports cartilage regeneration without the cell harvesting and laboratory processing required by some alternative approaches. Regentis is continuing enrollment in its U.S. clinical study, preparing for a potential FDA Premarket Approval submission, expanding commercialization efforts in Europe following CE Mark approval, and optimizing manufacturing for scalability and consistency. To view the full article, visit https://ibn.fm/mVCsB About Regentis Biomaterials Ltd. Regentis Biomaterials is a…

FridayAug 07, 2026 2:12 pm

QualityStocksNewsBreaks – Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Advances Two-Pronged Approach to Neurological Health

Disseminated on behalf of Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) and may include paid advertising. Quantum BioPharma (NASDAQ: QNTM) (CSE: QNTM), a biopharmaceutical company focused on advancing innovative therapies and technologies, is developing a two-pronged strategy addressing neurological health through its investigational multiple sclerosis therapy Lucid-MS and its proprietary dietary supplement unbuzzd. Lucid-MS is designed to target PAD2, an enzyme associated with myelin degradation, with the goal of protecting and potentially restoring the myelin sheath rather than primarily modulating the immune system. The company submitted an IND application to the FDA for a Phase 2 trial and is supporting development through an imaging collaboration…

Site Search

Company Search